Maat Pharma SA
MAAT.PA
$8.42
Closing
▼-1.47%
1D
▲0.75%
YTD
MAAT
BBG00RMZCCQ0
Check if the stock is halal
Unlock Industry-grade Shariah Compliance for global stocks. See results from 5 major Shariah standards: AAOIFI, S&P, DJIM, FTSE and MSCI.
We provide unparalleled value and service.
Screened by AAOIFI Certified Shariah Advisor & Auditor.
Get started from just $6.99/month
Market cap
$116.76M
Analysts' Rating
STRONG BUY
Price Target (Mean)
16.98
Total Analysts
3
P/E
Operating Margin
-1058.17%
Beta
Revenue Growth
24.89%
52 week high
$10.45
52 week low
$6.84
Div. Yield
%
EPS Growth
0.00
Company Profile
Maat Pharma SA is a France-based company, which is engaged into research and development in biotechnology sector. The Company specializes in the microbiome therapy that is aimed to treatment of Gut Microbiota alteration (Dysbiosis) using patient-specific biotherapeutics in patients with serious medical conditions. Its MaaT Microbiome Restoration Therapy (MMRB) discovery and analysis platform supports the evaluation of drug candidates, the determination of new disease targets and the identification of biomarkers for microbiome-related conditions.
